scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.271.45.28485 |
10.1074/JBC.271.45.28630 | ||
P3181 | OpenCitations bibliographic resource ID | 3293371 |
P698 | PubMed publication ID | 8910476 |
P2093 | author name string | J. Chen | |
C. M. Giachelli | |||
L. E. Ling | |||
L. L. Smith | |||
D. Sheppard | |||
R. Pytela | |||
H. K. Cheung | |||
P2860 | cites work | Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle | Q24320026 |
The cDNA and derived amino acid sequence for human osteopontin | Q24635888 | ||
Integrins: versatility, modulation, and signaling in cell adhesion | Q27860844 | ||
cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN) | Q28258326 | ||
Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen | Q28286740 | ||
Distribution of integrins alpha v beta 6 and alpha 9 beta 1 and their known ligands, fibronectin and tenascin, in human airways | Q28287852 | ||
A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5 | Q28291862 | ||
Localized distribution of alpha 9 integrin in the cornea and changes in expression during corneal epithelial cell differentiation | Q28511788 | ||
Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques | Q33904134 | ||
The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro | Q34201497 | ||
Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain | Q34442820 | ||
Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo | Q35596525 | ||
Identification of multiple cell adhesion receptors for collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and common beta subunits | Q36216852 | ||
Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin | Q36221398 | ||
The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells | Q36222939 | ||
Integrin beta 3 cytoplasmic tail is necessary and sufficient for regulation of alpha 5 beta 1 phagocytosis by alpha v beta 3 and integrin-associated protein | Q36235842 | ||
Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. | Q37374564 | ||
Molecular and cellular biology of osteopontin Potential role in cardiovascular disease | Q37828199 | ||
The extracellular matrix as a cell survival factor | Q40241699 | ||
Recombinant GST-human osteopontin fusion protein is functional in RGD-dependent cell adhesion | Q41490633 | ||
The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platel | Q41563203 | ||
Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells | Q41740694 | ||
Expression of wild-type and mutated rabbit osteopontin in Escherichia coli, and their effects on adhesion and migration of P388D1 cells | Q41869461 | ||
Site-directed mutagenesis of the arginine-glycine-aspartic acid sequence in osteopontin destroys cell adhesion and migration functions | Q42829047 | ||
A monoclonal antibody to beta 1 integrin (CD29) stimulates VLA-dependent adherence of leukocytes to human umbilical vein endothelial cells and matrix components | Q43108177 | ||
Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin | Q57615757 | ||
P433 | issue | 45 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 28485–28491 | |
P577 | publication date | 1996-11-08 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin | |
P478 | volume | 271 |
Q36389313 | A complex of α6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6 |
Q40371624 | A new model for lymphatic metastasis: development of a variant of the MDA-MB-468 human breast cancer cell line that aggressively metastasizes to lymph nodes |
Q34784777 | A novel cryptic binding motif, LRSKSRSFQVSDEQY, in the C-terminal fragment of MMP-3/7-cleaved osteopontin as a novel ligand for α9β1 integrin is involved in the anti-type II collagen antibody-induced arthritis |
Q45888321 | A novel peptide, PLAEIDGIELTY, for the targeting of alpha9beta1-integrins |
Q36928308 | Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy |
Q51810326 | Adhesive protein interactions with chitosan: Consequences for valve endothelial cell growth on tissue‐engineering materials |
Q73704105 | Alpha(1)-proteinase inhibitor, alpha(1)-antichymotrypsin, or alpha(2)-macroglobulin is required for vascular smooth muscle cell spreading in three-dimensional fibrin gel |
Q28581565 | Alpha9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration |
Q24554478 | BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site |
Q28247388 | BRCA1 phosphorylation by Aurora-A in the regulation of G2 to M transition |
Q50592080 | Brief Report: Factors Released by Megakaryocytes Thrombin Cleave Osteopontin to Negatively Regulate Hematopoietic Stem Cells. |
Q24673965 | CBP/p300 interact with and function as transcriptional coactivators of BRCA1 |
Q38326853 | CD44 is not an adhesive receptor for osteopontin |
Q30496149 | Cancer biomarker discovery: the entropic hallmark |
Q24645684 | Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains |
Q44601512 | Characterization and analysis of osteopontin‐immobilized poly(2‐hydroxyethyl methacrylate) surfaces |
Q28140621 | Chimeric peptides of statherin and osteopontin that bind hydroxyapatite and mediate cell adhesion |
Q36228392 | Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis |
Q35019922 | Consolidated and emerging inflammatory markers in coronary artery disease |
Q47129305 | Constitutive Activation of Integrin α9 Augments Self-Directed Hyperplastic and Proinflammatory Properties of Fibroblast-like Synoviocytes of Rheumatoid Arthritis |
Q30442047 | Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin |
Q36973689 | Dentin matrix protein-1 isoforms promote differential cell attachment and migration |
Q40307101 | Dentin sialophosphoprotein (DSPP) is cleaved into its two natural dentin matrix products by three isoforms of bone morphogenetic protein-1 (BMP1). |
Q33954396 | Elevated levels of full-length and thrombin-cleaved osteopontin during acute dengue virus infection are associated with coagulation abnormalities. |
Q35763795 | Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo |
Q37290004 | Expression Patterns of Extracellular Matrix Proteins during Posterior Commissure Development |
Q27006822 | Extracellular matrix as an inductive scaffold for functional tissue reconstruction |
Q33964642 | Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. |
Q33716333 | Functions of the extracellular matrix and matrix degrading proteases during tumor progression |
Q39261041 | Human osteopontin: Potential clinical applications in cancer (Review) |
Q73694096 | Identification of dual alpha 4beta1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin |
Q30365463 | Identification of the peptide sequences within the EIIIA (EDA) segment of fibronectin that mediate integrin alpha9beta1-dependent cellular activities. |
Q44031899 | Immunodetection of osteopontin at sites of resorption in the pulp of rat molars |
Q34098674 | Increased expression of tenascin-C-binding epithelial integrins in human bullous keratopathy corneas |
Q40864152 | Inhibitory effects of MLDG-containing heterodimeric disintegrins reveal distinct structural requirements for interaction of the integrin alpha 9beta 1 with VCAM-1, tenascin-C, and osteopontin |
Q44499297 | Integrin alpha4beta1 (VLA-4) expression and activity in retinal and peripheral neurons |
Q37434526 | Integrin alpha8beta1 regulates adhesion, migration and proliferation of human intestinal crypt cells via a predominant RhoA/ROCK-dependent mechanism |
Q37347702 | Integrin alpha9 beta1 is a receptor for nerve growth factor and other neurotrophins |
Q30525167 | Integrin α9β1 in airway smooth muscle suppresses exaggerated airway narrowing |
Q24301960 | Interaction of alpha9beta1 integrin with thrombospondin-1 promotes angiogenesis |
Q35636511 | MMP induction and inhibition in myocardial infarction |
Q44414977 | Mammary tumor development in MMTV-c-myc/MMTV-v-Ha-ras transgenic mice is unaffected by osteopontin deficiency |
Q28749320 | Molecular evolution of dentin phosphoprotein among toothed and toothless animals |
Q92487005 | Monocyte recruitment and activated inflammation are associated with thyroid carcinogenesis in a mouse model |
Q36091701 | Myocardial Expression Analysis of Osteopontin and Its Splice Variants in Patients Affected by End-Stage Idiopathic or Ischemic Dilated Cardiomyopathy. |
Q35028997 | Novel functions of the matricellular proteins osteopontin and osteonectin/SPARC. |
Q36355935 | Osteopontin (OPN/SPP1) isoforms collectively enhance tumor cell invasion and dissemination in esophageal adenocarcinoma |
Q37821498 | Osteopontin and allergic disease: pathophysiology and implications for diagnostics and therapy |
Q37734385 | Osteopontin attenuates aging-associated phenotypes of hematopoietic stem cells |
Q73226519 | Osteopontin deficiency in rat vascular smooth muscle cells is associated with an inability to adhere to collagen and increased apoptosis |
Q37301330 | Osteopontin expression and function within the dorsal root ganglion |
Q28307824 | Osteopontin expression by CD103- dendritic cells drives intestinal inflammation |
Q37872380 | Osteopontin in macrophage function |
Q38181994 | Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies |
Q42799564 | Osteopontin is required for full expression of the transformed phenotype by the ras oncogene |
Q28509843 | Osteopontin undergoes polymerization in vivo and gains chemotactic activity for neutrophils mediated by integrin alpha9beta1. |
Q43862137 | Osteopontin(OPN)-induced increase in human mammary epithelial cell invasiveness is urokinase (uPA)-dependent |
Q50335757 | Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). |
Q34216288 | Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation |
Q37703338 | Osteopontin: an effector and an effect of tumor metastasis. |
Q34218572 | Osteopontin: roles in implantation and placentation |
Q42604556 | Parsing the niche code: the molecular mechanisms governing hematopoietic stem cell adhesion and differentiation |
Q46290199 | Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification |
Q80818189 | Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis |
Q82661061 | Plasma thrombin-cleaved osteopontin elevation after carotid artery stenting in symptomatic ischemic stroke patients |
Q34332597 | Plasmin-induced migration requires signaling through protease-activated receptor 1 and integrin alpha(9)beta(1). |
Q36127186 | Polydom/SVEP1 is a ligand for integrin α9β1. |
Q30487764 | Polymeric osteopontin employs integrin alpha9beta1 as a receptor and attracts neutrophils by presenting a de novo binding site |
Q34939938 | Pre- and post-translational regulation of osteopontin in cancer |
Q34114355 | Protein targets of inflammatory serine proteases and cardiovascular disease |
Q47109997 | Recombinant human osteopontin expressed in Nicotiana benthamiana stimulates osteogenesis related genes in human periodontal ligament cells |
Q33904614 | Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules |
Q39905965 | Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma. |
Q42502311 | SVEP1 plays a crucial role in epidermal differentiation |
Q38859940 | SVVYGLR motif of the thrombin-cleaved N-terminal osteopontin fragment enhances the synthesis of collagen type III in myocardial fibrosis |
Q24676154 | Spermidine/spermine N1-acetyltransferase specifically binds to the integrin alpha9 subunit cytoplasmic domain and enhances cell migration |
Q37632122 | Suppression of tumour growth by orally administered osteopontin is accompanied by alterations in tumour blood vessels |
Q45863573 | Targeted gene delivery into alpha9beta1-integrin-displaying cells by a synthetic peptide |
Q33737602 | The cytokine osteopontin modulates the severity of rotavirus diarrhea |
Q34022649 | The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease |
Q37371674 | The hedgehog pathway transcription factor GLI1 promotes malignant behavior of cancer cells by up-regulating osteopontin |
Q28647112 | The integrin alpha9beta1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1 |
Q42604585 | The integrin alpha9beta1 on hematopoietic stem and progenitor cells: involvement in cell adhesion, proliferation and differentiation |
Q34639848 | The role of osteopontin in breast cancer: clinical and experimental studies |
Q37424204 | The role of osteopontin in inflammatory processes |
Q47702484 | The role of α9β1 integrin and its ligands in the development of autoimmune diseases |
Q46142052 | Thrombin Activatable Fibrinolysis Inhibitor, a Potential Regulator of Vascular Inflammation |
Q36606627 | Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis? |
Q57797684 | Thrombin cleavage of osteopontin controls activation of hepatic stellate cells and is essential for liver fibrogenesis |
Q34245106 | Thrombin cleavage of osteopontin disrupts a pro-chemotactic sequence for dendritic cells, which is compensated by the release of its pro-chemotactic C-terminal fragment |
Q39648432 | Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma |
Q42626618 | Tissue transglutaminase, coagulation factor XIII, and the pro-polypeptide of von Willebrand factor are all ligands for the integrins alpha 9beta 1 and alpha 4beta 1. |
Q24296797 | Transcriptional regulation of human FE65, a ligand of Alzheimer's disease amyloid precursor protein, by Sp1 |
Q39652140 | Transglutaminase-mediated oligomerization promotes osteoblast adhesive properties of osteopontin and bone sialoprotein |
Q38780981 | Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression |
Search more.